M S Villaverde
Overview
Explore the profile of M S Villaverde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perona M, Ibanez I, Thomasz L, Villaverde M, Oglio R, Rosemblit C, et al.
J Endocrinol Invest
. 2023 Apr;
46(11):2353-2365.
PMID: 37052871
Background: Anaplastic thyroid cancer (ATC) represents a rare lethal human malignancy with poor prognosis. Multimodality treatment, including radiotherapy, is recommended to improve local control and survival. Valproic acid (VA) is...
2.
Villaverde M, Gil-Cardeza M, Glikin G, Finocchiaro L
Cancer Gene Ther
. 2012 May;
19(7):508-16.
PMID: 22595795
We evaluated the effect of hIFNβ gene transfer alone or in combination with different antineoplastic drugs commonly used in cancer treatment. Five human tumor-derived cell lines were cultured as monolayers...
3.
Villaverde M, Gil-Cardeza M, Glikin G, Finocchiaro L
Cancer Gene Ther
. 2012 May;
19(6):420-30.
PMID: 22555508
We evaluated the cytotoxic effects (apoptosis, necrosis and early senescence) of human interferon-β (hIFNβ) gene lipofection. The cytotoxicity of hIFNβ gene lipofection resulted equivalent to that of the corresponding addition...
4.
Gil-Cardeza M, Villaverde M, Fiszman G, Altamirano N, Cwirenbaum R, Glikin G, et al.
Gene Ther
. 2009 Sep;
17(1):26-36.
PMID: 19741734
To validate the use of multicellular spheroids to predict the efficacy of herpes simplex thymidine kinase/ganciclovir (HSVtk/GCV) suicide gene therapy in the respective in vivo tumors, we established and characterized...